Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
POSITIVE PHYSICIANS HOLDINGS,INC. (PPHI)
|
|
| Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-20 | Mar-31-20 | Dec-31-19 | Sep-30-19 | Jun-30-19 | Mar-31-19 | Dec-31-18 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 24.1 | 24.5 | 28.0 | 26.9 | 25.4 | 25.2 | 24.6 |
| Revenue growth | -5.3% | -2.8% | 13.6% | | | | |
| Loss and loss adjustment expenses | 14.4 | 15.4 | 15.6 | 19.5 | 19.2 | 19.6 | 19.6 |
| Policy acquisition costs | 5.7 | 7.0 | 7.9 | 8.4 | 8.3 | 10.2 | 10.4 |
| Other underwriting costs | 11.0 | 11.5 | 12.6 | 13.1 | 12.7 | 12.8 | 12.3 |
| Investment expenses | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Other operating expenses | -5.8 | -7.1 | -8.0 | -8.5 | -8.5 | -10.3 | -10.5 |
| EBITDA | 0.5 | -0.6 | 1.3 | -4.7 | -6.0 | -7.9 | -8.5 |
| EBITDA margin | 2.1% | -2.4% | 4.5% | -17.4% | -23.8% | -31.4% | -34.4% |
| Depreciation | 1.8 | 1.8 | 1.5 | 1.1 | 0.4 | 0.1 | 0.1 |
| EBIT | -1.3 | -2.4 | -0.2 | -5.8 | -6.5 | -8.0 | -8.6 |
| EBIT margin | -5.6% | -9.9% | -0.8% | -21.6% | -25.4% | -31.7% | -34.8% |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.8 | -1.3 |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax income | -1.3 | -2.4 | -0.2 | -5.8 | -6.5 | -7.2 | -7.3 |
| Income taxes | -0.8 | -1.0 | 0.0 | -1.6 | -1.8 | -1.8 | -1.9 |
| Tax rate | | 39.9% | -3.0% | 27.3% | 27.3% | 25.6% | 26.5% |
| Net income | -0.5 | -1.5 | -0.2 | -4.2 | -4.7 | -5.3 | -5.4 |
| Net margin | -2.2% | -5.9% | -0.9% | -15.7% | -18.5% | -21.2% | -21.8% |
| |
| Basic EPS | ($0.30) | ($0.80) | ($0.14) | ($2.53) | ($2.81) | ($6.97) | |
| Diluted EPS | ($0.30) | ($0.80) | ($0.14) | ($2.53) | ($2.81) | ($6.97) | |
| |
| Shares outstanding (basic) | 1.8 | 1.8 | 1.7 | | 1.7 | 0.8 | |
| Shares outstanding (diluted) | 1.8 | 1.8 | 1.7 | | 1.7 | 0.8 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|